Ontology type: schema:ScholarlyArticle Open Access: True
2022-04-08
AUTHORSEvanthia Gouveri, Nikolaos Papanas
ABSTRACTThe aim of this narrative review is to present data on the role of continuous glucose monitoring (CGM) in the management of peripheral diabetic neuropathy (DPN) among individuals with type 1 and type 2 diabetes mellitus. Adequate glycaemic control is crucial to prevent the development or progression of DPN. CGM systems are valuable tools for improving glycaemic control and reducing glycaemic variability (GV). Chronic hyperglycaemia is known to be a risk factor for the development of diabetic microvascular complications, including DPN. In addition, there is now evidence that GV, evaluated by mean amplitude of glycaemic excursions, may be a novel factor in the pathogenesis of diabetic complications. Increased GV appears to be an independent risk factor for DPN and correlates with painful neuropathy. Similarly, time-in-range correlates positively with peripheral nerve function and negatively with sudomotor dysfunction. However, relevant studies are rather limited in scope, and the vast majority are cross-sectional and use different methodologies for the assessment of DPN. Therefore, the causal relationship between CGM-derived data and the development of DPN cannot be firmly established at the present time. It also remains to be elucidated whether CGM measures can be considered the new therapeutic targets for DPN management. More... »
PAGES931-952
http://scigraph.springernature.com/pub.10.1007/s13300-022-01257-5
DOIhttp://dx.doi.org/10.1007/s13300-022-01257-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1146960419
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/35394566
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Diabetes Centre Dr. Tews, 63571, Gelnhausen-Hessen, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Diabetes Centre Dr. Tews, 63571, Gelnhausen-Hessen, Germany"
],
"type": "Organization"
},
"familyName": "Gouveri",
"givenName": "Evanthia",
"id": "sg:person.01356145302.77",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356145302.77"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68132, Alexandroupolis, Greece",
"id": "http://www.grid.ac/institutes/grid.12284.3d",
"name": [
"Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68132, Alexandroupolis, Greece"
],
"type": "Organization"
},
"familyName": "Papanas",
"givenName": "Nikolaos",
"id": "sg:person.0747501146.39",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747501146.39"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s12020-016-1005-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046649696",
"https://doi.org/10.1007/s12020-016-1005-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00592-019-01450-2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1122411537",
"https://doi.org/10.1007/s00592-019-01450-2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1758-5996-6-139",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027090950",
"https://doi.org/10.1186/1758-5996-6-139"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/s42003-021-02896-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1143660219",
"https://doi.org/10.1038/s42003-021-02896-3"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s13300-019-0619-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1113808744",
"https://doi.org/10.1007/s13300-019-0619-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13098-021-00739-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1142179290",
"https://doi.org/10.1186/s13098-021-00739-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12020-018-1546-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1100856500",
"https://doi.org/10.1007/s12020-018-1546-z"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s12933-020-01085-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1128995204",
"https://doi.org/10.1186/s12933-020-01085-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/s13098-018-0371-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1106942554",
"https://doi.org/10.1186/s13098-018-0371-0"
],
"type": "CreativeWork"
}
],
"datePublished": "2022-04-08",
"datePublishedReg": "2022-04-08",
"description": "The aim of this narrative review is to present data on the role of continuous glucose monitoring (CGM) in the management of peripheral diabetic neuropathy (DPN) among individuals with type 1 and type 2 diabetes mellitus. Adequate glycaemic control is crucial to prevent the development or progression of DPN. CGM systems are valuable tools for improving glycaemic control and reducing glycaemic variability (GV). Chronic hyperglycaemia is known to be a risk factor for the development of diabetic microvascular complications, including DPN. In addition, there is now evidence that GV, evaluated by mean amplitude of glycaemic excursions, may be a novel factor in the pathogenesis of diabetic complications. Increased GV appears to be an independent risk factor for DPN and correlates with painful neuropathy. Similarly, time-in-range correlates positively with peripheral nerve function and negatively with sudomotor dysfunction. However, relevant studies are rather limited in scope, and the vast majority are cross-sectional and use different methodologies for the assessment of DPN. Therefore, the causal relationship between CGM-derived data and the development of DPN cannot be firmly established at the present time. It also remains to be elucidated whether CGM measures can be considered the new therapeutic targets for DPN management.",
"genre": "article",
"id": "sg:pub.10.1007/s13300-022-01257-5",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1044057",
"issn": [
"1869-6953",
"1869-6961"
],
"name": "Diabetes Therapy",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "13"
}
],
"keywords": [
"continuous glucose monitoring",
"glycaemic variability",
"glycaemic control",
"risk factors",
"narrative review",
"type 2 diabetes mellitus",
"glucose monitoring",
"peripheral diabetic neuropathy",
"adequate glycaemic control",
"development of DPN",
"diabetic microvascular complications",
"diabetic peripheral neuropathy",
"independent risk factor",
"peripheral nerve function",
"new therapeutic targets",
"painful neuropathy",
"microvascular complications",
"diabetic neuropathy",
"nerve function",
"diabetes mellitus",
"chronic hyperglycaemia",
"sudomotor dysfunction",
"peripheral neuropathy",
"glycaemic excursions",
"diabetic complications",
"therapeutic target",
"neuropathy",
"type 1",
"CGM measures",
"relevant studies",
"Emerging Role",
"complications",
"mean amplitude",
"CGM systems",
"novel factor",
"DPN",
"vast majority",
"mellitus",
"hyperglycaemia",
"review",
"dysfunction",
"causal relationship",
"pathogenesis",
"management",
"factors",
"progression",
"valuable tool",
"control",
"role",
"correlates",
"aim",
"majority",
"monitoring",
"individuals",
"development",
"assessment",
"evidence",
"present time",
"target",
"data",
"study",
"measures",
"time",
"excursion",
"function",
"addition",
"relationship",
"variability",
"amplitude",
"different methodologies",
"tool",
"system",
"scope",
"methodology"
],
"name": "The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review",
"pagination": "931-952",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1146960419"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s13300-022-01257-5"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"35394566"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s13300-022-01257-5",
"https://app.dimensions.ai/details/publication/pub.1146960419"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:11",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_934.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s13300-022-01257-5"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01257-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01257-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01257-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01257-5'
This table displays all metadata directly associated to this object as RDF triples.
181 TRIPLES
21 PREDICATES
108 URIs
91 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s13300-022-01257-5 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1103 |
3 | ″ | schema:author | N0dd3fbc322d44b89b4fb5f7e0c4da1f6 |
4 | ″ | schema:citation | sg:pub.10.1007/s00592-019-01450-2 |
5 | ″ | ″ | sg:pub.10.1007/s12020-016-1005-7 |
6 | ″ | ″ | sg:pub.10.1007/s12020-018-1546-z |
7 | ″ | ″ | sg:pub.10.1007/s13300-019-0619-1 |
8 | ″ | ″ | sg:pub.10.1038/s42003-021-02896-3 |
9 | ″ | ″ | sg:pub.10.1186/1758-5996-6-139 |
10 | ″ | ″ | sg:pub.10.1186/s12933-020-01085-6 |
11 | ″ | ″ | sg:pub.10.1186/s13098-018-0371-0 |
12 | ″ | ″ | sg:pub.10.1186/s13098-021-00739-z |
13 | ″ | schema:datePublished | 2022-04-08 |
14 | ″ | schema:datePublishedReg | 2022-04-08 |
15 | ″ | schema:description | The aim of this narrative review is to present data on the role of continuous glucose monitoring (CGM) in the management of peripheral diabetic neuropathy (DPN) among individuals with type 1 and type 2 diabetes mellitus. Adequate glycaemic control is crucial to prevent the development or progression of DPN. CGM systems are valuable tools for improving glycaemic control and reducing glycaemic variability (GV). Chronic hyperglycaemia is known to be a risk factor for the development of diabetic microvascular complications, including DPN. In addition, there is now evidence that GV, evaluated by mean amplitude of glycaemic excursions, may be a novel factor in the pathogenesis of diabetic complications. Increased GV appears to be an independent risk factor for DPN and correlates with painful neuropathy. Similarly, time-in-range correlates positively with peripheral nerve function and negatively with sudomotor dysfunction. However, relevant studies are rather limited in scope, and the vast majority are cross-sectional and use different methodologies for the assessment of DPN. Therefore, the causal relationship between CGM-derived data and the development of DPN cannot be firmly established at the present time. It also remains to be elucidated whether CGM measures can be considered the new therapeutic targets for DPN management. |
16 | ″ | schema:genre | article |
17 | ″ | schema:isAccessibleForFree | true |
18 | ″ | schema:isPartOf | N0d240927f9d24a7d988824e4455942e6 |
19 | ″ | ″ | Nd833e1ee22cd41b79e7ba6e6a34f9cfb |
20 | ″ | ″ | sg:journal.1044057 |
21 | ″ | schema:keywords | CGM measures |
22 | ″ | ″ | CGM systems |
23 | ″ | ″ | DPN |
24 | ″ | ″ | Emerging Role |
25 | ″ | ″ | addition |
26 | ″ | ″ | adequate glycaemic control |
27 | ″ | ″ | aim |
28 | ″ | ″ | amplitude |
29 | ″ | ″ | assessment |
30 | ″ | ″ | causal relationship |
31 | ″ | ″ | chronic hyperglycaemia |
32 | ″ | ″ | complications |
33 | ″ | ″ | continuous glucose monitoring |
34 | ″ | ″ | control |
35 | ″ | ″ | correlates |
36 | ″ | ″ | data |
37 | ″ | ″ | development |
38 | ″ | ″ | development of DPN |
39 | ″ | ″ | diabetes mellitus |
40 | ″ | ″ | diabetic complications |
41 | ″ | ″ | diabetic microvascular complications |
42 | ″ | ″ | diabetic neuropathy |
43 | ″ | ″ | diabetic peripheral neuropathy |
44 | ″ | ″ | different methodologies |
45 | ″ | ″ | dysfunction |
46 | ″ | ″ | evidence |
47 | ″ | ″ | excursion |
48 | ″ | ″ | factors |
49 | ″ | ″ | function |
50 | ″ | ″ | glucose monitoring |
51 | ″ | ″ | glycaemic control |
52 | ″ | ″ | glycaemic excursions |
53 | ″ | ″ | glycaemic variability |
54 | ″ | ″ | hyperglycaemia |
55 | ″ | ″ | independent risk factor |
56 | ″ | ″ | individuals |
57 | ″ | ″ | majority |
58 | ″ | ″ | management |
59 | ″ | ″ | mean amplitude |
60 | ″ | ″ | measures |
61 | ″ | ″ | mellitus |
62 | ″ | ″ | methodology |
63 | ″ | ″ | microvascular complications |
64 | ″ | ″ | monitoring |
65 | ″ | ″ | narrative review |
66 | ″ | ″ | nerve function |
67 | ″ | ″ | neuropathy |
68 | ″ | ″ | new therapeutic targets |
69 | ″ | ″ | novel factor |
70 | ″ | ″ | painful neuropathy |
71 | ″ | ″ | pathogenesis |
72 | ″ | ″ | peripheral diabetic neuropathy |
73 | ″ | ″ | peripheral nerve function |
74 | ″ | ″ | peripheral neuropathy |
75 | ″ | ″ | present time |
76 | ″ | ″ | progression |
77 | ″ | ″ | relationship |
78 | ″ | ″ | relevant studies |
79 | ″ | ″ | review |
80 | ″ | ″ | risk factors |
81 | ″ | ″ | role |
82 | ″ | ″ | scope |
83 | ″ | ″ | study |
84 | ″ | ″ | sudomotor dysfunction |
85 | ″ | ″ | system |
86 | ″ | ″ | target |
87 | ″ | ″ | therapeutic target |
88 | ″ | ″ | time |
89 | ″ | ″ | tool |
90 | ″ | ″ | type 1 |
91 | ″ | ″ | type 2 diabetes mellitus |
92 | ″ | ″ | valuable tool |
93 | ″ | ″ | variability |
94 | ″ | ″ | vast majority |
95 | ″ | schema:name | The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review |
96 | ″ | schema:pagination | 931-952 |
97 | ″ | schema:productId | N543e15e9ef44488e90a4fe17dc4bfc69 |
98 | ″ | ″ | N7365aaeb5c6744efa962958c8df5416b |
99 | ″ | ″ | N9cbed241f1b54b10b407ed45df716022 |
100 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1146960419 |
101 | ″ | ″ | https://doi.org/10.1007/s13300-022-01257-5 |
102 | ″ | schema:sdDatePublished | 2022-08-04T17:11 |
103 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
104 | ″ | schema:sdPublisher | N140cc0df887142a8b9ca2524ad6aae9c |
105 | ″ | schema:url | https://doi.org/10.1007/s13300-022-01257-5 |
106 | ″ | sgo:license | sg:explorer/license/ |
107 | ″ | sgo:sdDataset | articles |
108 | ″ | rdf:type | schema:ScholarlyArticle |
109 | N0d240927f9d24a7d988824e4455942e6 | schema:volumeNumber | 13 |
110 | ″ | rdf:type | schema:PublicationVolume |
111 | N0dd3fbc322d44b89b4fb5f7e0c4da1f6 | rdf:first | sg:person.01356145302.77 |
112 | ″ | rdf:rest | N8d62e626b08745fdbf353d4e7bced746 |
113 | N140cc0df887142a8b9ca2524ad6aae9c | schema:name | Springer Nature - SN SciGraph project |
114 | ″ | rdf:type | schema:Organization |
115 | N543e15e9ef44488e90a4fe17dc4bfc69 | schema:name | dimensions_id |
116 | ″ | schema:value | pub.1146960419 |
117 | ″ | rdf:type | schema:PropertyValue |
118 | N7365aaeb5c6744efa962958c8df5416b | schema:name | pubmed_id |
119 | ″ | schema:value | 35394566 |
120 | ″ | rdf:type | schema:PropertyValue |
121 | N8d62e626b08745fdbf353d4e7bced746 | rdf:first | sg:person.0747501146.39 |
122 | ″ | rdf:rest | rdf:nil |
123 | N9cbed241f1b54b10b407ed45df716022 | schema:name | doi |
124 | ″ | schema:value | 10.1007/s13300-022-01257-5 |
125 | ″ | rdf:type | schema:PropertyValue |
126 | Nd833e1ee22cd41b79e7ba6e6a34f9cfb | schema:issueNumber | 5 |
127 | ″ | rdf:type | schema:PublicationIssue |
128 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
129 | ″ | schema:name | Medical and Health Sciences |
130 | ″ | rdf:type | schema:DefinedTerm |
131 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
132 | ″ | schema:name | Clinical Sciences |
133 | ″ | rdf:type | schema:DefinedTerm |
134 | sg:journal.1044057 | schema:issn | 1869-6953 |
135 | ″ | ″ | 1869-6961 |
136 | ″ | schema:name | Diabetes Therapy |
137 | ″ | schema:publisher | Springer Nature |
138 | ″ | rdf:type | schema:Periodical |
139 | sg:person.01356145302.77 | schema:affiliation | grid-institutes:None |
140 | ″ | schema:familyName | Gouveri |
141 | ″ | schema:givenName | Evanthia |
142 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356145302.77 |
143 | ″ | rdf:type | schema:Person |
144 | sg:person.0747501146.39 | schema:affiliation | grid-institutes:grid.12284.3d |
145 | ″ | schema:familyName | Papanas |
146 | ″ | schema:givenName | Nikolaos |
147 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747501146.39 |
148 | ″ | rdf:type | schema:Person |
149 | sg:pub.10.1007/s00592-019-01450-2 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1122411537 |
150 | ″ | ″ | https://doi.org/10.1007/s00592-019-01450-2 |
151 | ″ | rdf:type | schema:CreativeWork |
152 | sg:pub.10.1007/s12020-016-1005-7 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1046649696 |
153 | ″ | ″ | https://doi.org/10.1007/s12020-016-1005-7 |
154 | ″ | rdf:type | schema:CreativeWork |
155 | sg:pub.10.1007/s12020-018-1546-z | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1100856500 |
156 | ″ | ″ | https://doi.org/10.1007/s12020-018-1546-z |
157 | ″ | rdf:type | schema:CreativeWork |
158 | sg:pub.10.1007/s13300-019-0619-1 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1113808744 |
159 | ″ | ″ | https://doi.org/10.1007/s13300-019-0619-1 |
160 | ″ | rdf:type | schema:CreativeWork |
161 | sg:pub.10.1038/s42003-021-02896-3 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1143660219 |
162 | ″ | ″ | https://doi.org/10.1038/s42003-021-02896-3 |
163 | ″ | rdf:type | schema:CreativeWork |
164 | sg:pub.10.1186/1758-5996-6-139 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1027090950 |
165 | ″ | ″ | https://doi.org/10.1186/1758-5996-6-139 |
166 | ″ | rdf:type | schema:CreativeWork |
167 | sg:pub.10.1186/s12933-020-01085-6 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1128995204 |
168 | ″ | ″ | https://doi.org/10.1186/s12933-020-01085-6 |
169 | ″ | rdf:type | schema:CreativeWork |
170 | sg:pub.10.1186/s13098-018-0371-0 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1106942554 |
171 | ″ | ″ | https://doi.org/10.1186/s13098-018-0371-0 |
172 | ″ | rdf:type | schema:CreativeWork |
173 | sg:pub.10.1186/s13098-021-00739-z | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1142179290 |
174 | ″ | ″ | https://doi.org/10.1186/s13098-021-00739-z |
175 | ″ | rdf:type | schema:CreativeWork |
176 | grid-institutes:None | schema:alternateName | Diabetes Centre Dr. Tews, 63571, Gelnhausen-Hessen, Germany |
177 | ″ | schema:name | Diabetes Centre Dr. Tews, 63571, Gelnhausen-Hessen, Germany |
178 | ″ | rdf:type | schema:Organization |
179 | grid-institutes:grid.12284.3d | schema:alternateName | Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68132, Alexandroupolis, Greece |
180 | ″ | schema:name | Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68132, Alexandroupolis, Greece |
181 | ″ | rdf:type | schema:Organization |